Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Long-Term Deferred Tax (2017 - 2021)

Selectis Health's Long-Term Deferred Tax history spans 4 years, with the latest figure at $3.7 million for Q4 2020.

  • For Q4 2020, Long-Term Deferred Tax fell 70.86% year-over-year to $3.7 million; the TTM value through Dec 2020 reached $3.7 million, down 70.86%, while the annual FY2020 figure was $3.7 million, 70.86% down from the prior year.
  • Long-Term Deferred Tax for Q4 2020 was $3.7 million at Selectis Health, down from $12.6 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $13.0 million in Q4 2018 and bottomed at $3.7 million in Q4 2020.
  • The 4-year median for Long-Term Deferred Tax is $12.5 million (2017), against an average of $10.4 million.
  • The largest annual shift saw Long-Term Deferred Tax grew 4.59% in 2018 before it tumbled 70.86% in 2020.
  • A 4-year view of Long-Term Deferred Tax shows it stood at $12.4 million in 2017, then increased by 4.59% to $13.0 million in 2018, then decreased by 3.08% to $12.6 million in 2019, then crashed by 70.86% to $3.7 million in 2020.
  • Per Business Quant, the three most recent readings for GBCS's Long-Term Deferred Tax are $3.7 million (Q4 2020), $12.6 million (Q4 2019), and $13.0 million (Q4 2018).